Autolus Therapeutics PLCNASDAQ:AUTL
- LAST PRICE3.9800
- TODAY'S CHANGE (%)0.0800 (2.0513%)
- Bid / Lots3.8000/ 3
- Ask / Lots4.5000/ 1
- Open / Previous Close3.9200 / 3.9000
- Day Range
- 52 Week Range
- Volume347,405
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUTL |
|---|---|---|
| 09:32 ET | 10951 | 3.885 |
| 09:34 ET | 6372 | 3.92 |
| 09:36 ET | 3471 | 3.88 |
| 09:38 ET | 1472 | 3.875 |
| 09:39 ET | 2678 | 3.91 |
| 09:41 ET | 1700 | 3.915 |
| 09:43 ET | 500 | 3.91 |
| 09:45 ET | 400 | 3.9 |
| 09:48 ET | 100 | 3.89 |
| 09:50 ET | 200 | 3.9 |
| 09:52 ET | 400 | 3.89 |
| 09:54 ET | 1285 | 3.88 |
| 09:56 ET | 100 | 3.88 |
| 09:57 ET | 320 | 3.87 |
| 09:59 ET | 4221 | 3.84 |
| 10:01 ET | 1600 | 3.865 |
| 10:03 ET | 800 | 3.87 |
| 10:06 ET | 800 | 3.89 |
| 10:10 ET | 500 | 3.89 |
| 10:12 ET | 1400 | 3.875 |
| 10:15 ET | 1425 | 3.875 |
| 10:17 ET | 900 | 3.875 |
| 10:19 ET | 4725 | 3.89 |
| 10:21 ET | 600 | 3.905 |
| 10:24 ET | 400 | 3.89 |
| 10:28 ET | 3400 | 3.895 |
| 10:30 ET | 600 | 3.8837 |
| 10:32 ET | 200 | 3.895 |
| 10:33 ET | 500 | 3.885 |
| 10:35 ET | 100 | 3.885 |
| 10:37 ET | 1172 | 3.89 |
| 10:39 ET | 1000 | 3.89 |
| 10:42 ET | 300 | 3.895 |
| 10:44 ET | 100 | 3.89 |
| 10:48 ET | 2228 | 3.895 |
| 10:50 ET | 300 | 3.895 |
| 10:51 ET | 2100 | 3.915 |
| 10:55 ET | 200 | 3.925 |
| 11:00 ET | 300 | 3.925 |
| 11:02 ET | 33975 | 3.975 |
| 11:04 ET | 2340 | 3.955 |
| 11:06 ET | 450 | 3.95 |
| 11:08 ET | 548 | 3.955 |
| 11:09 ET | 200 | 3.95 |
| 11:11 ET | 2586 | 3.955 |
| 11:15 ET | 5448 | 3.9391 |
| 11:18 ET | 200 | 3.93 |
| 11:20 ET | 300 | 3.93 |
| 11:22 ET | 1649 | 3.92 |
| 11:24 ET | 754 | 3.905 |
| 11:26 ET | 300 | 3.905 |
| 11:27 ET | 520 | 3.9003 |
| 11:29 ET | 310 | 3.905 |
| 11:31 ET | 200 | 3.9006 |
| 11:36 ET | 4492 | 3.92 |
| 11:38 ET | 600 | 3.915 |
| 11:40 ET | 100 | 3.915 |
| 11:42 ET | 2268 | 3.915 |
| 11:44 ET | 110 | 3.915 |
| 11:45 ET | 500 | 3.91 |
| 11:47 ET | 300 | 3.91 |
| 11:56 ET | 700 | 3.925 |
| 11:58 ET | 1265 | 3.92 |
| 12:00 ET | 100 | 3.915 |
| 12:02 ET | 100 | 3.915 |
| 12:03 ET | 200 | 3.93 |
| 12:07 ET | 700 | 3.94 |
| 12:09 ET | 200 | 3.945 |
| 12:16 ET | 1000 | 3.945 |
| 12:18 ET | 100 | 3.945 |
| 12:20 ET | 410 | 3.965 |
| 12:21 ET | 300 | 3.96 |
| 12:23 ET | 112 | 3.955 |
| 12:27 ET | 100 | 3.95 |
| 12:30 ET | 200 | 3.945 |
| 12:36 ET | 500 | 3.945 |
| 12:38 ET | 329 | 3.9598 |
| 12:41 ET | 100 | 3.955 |
| 12:48 ET | 1310 | 3.95 |
| 12:52 ET | 500 | 3.95 |
| 12:54 ET | 126 | 3.9553 |
| 12:56 ET | 1187 | 3.955 |
| 12:57 ET | 220 | 3.955 |
| 12:59 ET | 910 | 3.94 |
| 01:06 ET | 100 | 3.95 |
| 01:08 ET | 100 | 3.9499 |
| 01:12 ET | 100 | 3.94 |
| 01:14 ET | 1507 | 3.955 |
| 01:15 ET | 100 | 3.955 |
| 01:24 ET | 100 | 3.95 |
| 01:26 ET | 1200 | 3.955 |
| 01:28 ET | 300 | 3.95 |
| 01:30 ET | 209 | 3.95 |
| 01:32 ET | 100 | 3.95 |
| 01:37 ET | 269 | 3.95 |
| 01:39 ET | 1487 | 3.94 |
| 01:44 ET | 200 | 3.955 |
| 01:46 ET | 100 | 3.95 |
| 01:48 ET | 100 | 3.95 |
| 01:50 ET | 500 | 3.95 |
| 01:51 ET | 200 | 3.945 |
| 01:55 ET | 300 | 3.94 |
| 01:57 ET | 500 | 3.935 |
| 02:00 ET | 2500 | 3.93 |
| 02:02 ET | 800 | 3.935 |
| 02:06 ET | 1320 | 3.94 |
| 02:08 ET | 500 | 3.93 |
| 02:11 ET | 100 | 3.93 |
| 02:13 ET | 2100 | 3.935 |
| 02:15 ET | 916 | 3.93 |
| 02:18 ET | 500 | 3.93 |
| 02:20 ET | 1681 | 3.93 |
| 02:22 ET | 509 | 3.935 |
| 02:24 ET | 400 | 3.935 |
| 02:26 ET | 210 | 3.935 |
| 02:27 ET | 200 | 3.935 |
| 02:29 ET | 5500 | 3.945 |
| 02:31 ET | 4128 | 3.935 |
| 02:33 ET | 1075 | 3.93 |
| 02:36 ET | 425 | 3.935 |
| 02:38 ET | 2469 | 3.95 |
| 02:44 ET | 200 | 3.94 |
| 02:45 ET | 200 | 3.94 |
| 02:47 ET | 1700 | 3.94 |
| 02:49 ET | 1873 | 3.935 |
| 02:51 ET | 327 | 3.935 |
| 02:54 ET | 100 | 3.935 |
| 02:56 ET | 1054 | 3.935 |
| 02:58 ET | 2524 | 3.94 |
| 03:00 ET | 1600 | 3.945 |
| 03:02 ET | 7659 | 3.945 |
| 03:03 ET | 576 | 3.95 |
| 03:05 ET | 2417 | 3.945 |
| 03:07 ET | 2908 | 3.945 |
| 03:09 ET | 2900 | 3.965 |
| 03:12 ET | 1200 | 3.96 |
| 03:14 ET | 200 | 3.965 |
| 03:16 ET | 3647 | 3.96 |
| 03:18 ET | 200 | 3.96 |
| 03:20 ET | 2600 | 3.96 |
| 03:21 ET | 1113 | 3.97 |
| 03:23 ET | 4852 | 3.975 |
| 03:25 ET | 2022 | 3.97 |
| 03:27 ET | 600 | 3.97 |
| 03:30 ET | 4696 | 3.965 |
| 03:32 ET | 3706 | 3.97 |
| 03:34 ET | 1500 | 3.965 |
| 03:36 ET | 676 | 3.965 |
| 03:38 ET | 2000 | 3.965 |
| 03:39 ET | 1600 | 3.965 |
| 03:41 ET | 1700 | 3.96 |
| 03:43 ET | 3389 | 3.95 |
| 03:45 ET | 1930 | 3.955 |
| 03:48 ET | 6722 | 3.965 |
| 03:50 ET | 200 | 3.965 |
| 03:52 ET | 6167 | 3.97 |
| 03:54 ET | 3700 | 3.965 |
| 03:56 ET | 12822 | 3.975 |
| 03:57 ET | 12676 | 3.98 |
| 03:59 ET | 24030 | 3.98 |
Sep 19, 2024
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer, from 7:00AM ET on Thursday Sep 19, 2024 by Dow Jones
7:00AM ET on Thursday Sep 19, 2024 by Dow JonesPress Release: Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer, from 7:00AM ET on Thursday Sep 19, 2024 by Dow Jones
7:00AM ET on Thursday Sep 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autolus Therapeutics PLC | 1.1B | -3.4x | --- |
Phathom Pharmaceuticals Inc | 1.0B | -3.4x | --- |
Pharvaris NV | 982.9M | -6.9x | --- |
Praxis Precision Medicines Inc | 1.2B | -6.3x | --- |
Tyra Biosciences Inc | 1.2B | -13.0x | --- |
Cullinan Therapeutics Inc | 947.3M | -5.3x | --- |
Company Information
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Contact Information
- Headquarters
- The Mediaworks, 191 Wood LaneLONDON, United Kingdom W12 7FP
- Phone
- 203-829-6230
- Fax
- ---
Executives
- Chairman of the Board
- Michael Bonney
- Chief Executive Officer, Executive Director
- Christian Itin
- Founder, Senior Vice President, Chief Scientific Officer
- Martin Pule
- Chief Financial Officer, Senior Vice President
- Lucinda Crabtree
- Chief Operating Officer, Senior Vice President
- Christopher Vann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 266.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.02 |
EPS | $-1.16 |
Book Value | --- |
P/E Ratio | -3.4x |
Price/Sales (TTM) | 100.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,775.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
